Sebastien Francis Duclos, PA-C
Physician Assistant · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Sebastien Francis Duclos’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A23230 · Cancelled
Licence status: Cancelled · since 1969 · Autonomous University of Guadalajara Faculty of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$141,888
Pharmacies billed $141,888 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
154 generic and 40 brand-name prescriptions · $141,888 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Acyclovir | 24 | $187 | $8 |
Year by year
| 2024 | 194 | 28 | None | 21% | $141,888 |
| 2023 | 145 | 16 | None | None | $36,627 |
| 2022 | 153 | 26 | None | None | $35,330 |
| 2021 | 216 | 28 | None | None | $29,117 |
| 2020 | 206 | 28 | None | 16% | $38,677 |
| 2019 | 429 | 46 | None | None | $83,449 |
| 2018 | 461 | 46 | None | None | $123,920 |
| 2017 | 431 | 35 | 3% (13) | 13% | $34,087 |
| 2016 | 167 | 29 | None | None | $7,721 |
| 2015 | 122 | 60 | 48% (58) | None | $5,445 |
| 2014 | 17 | 15 | 65% (11) | 0% | $221 |
| 2013 | 47 | 34 | 60% (28) | None | $733 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Potassium Chloride | 13 | $3,493 | $269 |
2021: 4 drugs
| Sevelamer Carbonate | 13 | $1,562 | $120 |
| Bumetanide | 11 | $1,260 | $115 |
| Carvedilol | 13 | $128 | $10 |
| Furosemide | 15 | $37 | $2 |
2020: 5 drugs
| Eplerenone | 11 | $1,055 | $96 |
| Acyclovir | 13 | $135 | $10 |
| Mirtazapine | 12 | $64 | $5 |
| Warfarin | 11 | $33 | $3 |
| Sulfamethoxazole-Trimethoprim | 12 | $28 | $2 |
2019: 13 drugs
| Sirolimus | 15 | $4,247 | $283 |
| Valganciclovir | 11 | $3,376 | $307 |
| Bumetanide | 20 | $2,370 | $119 |
| Clotrimazole | 11 | $464 | $42 |
| Isosorbide Mononitrate Er | 14 | $450 | $32 |
| Potassium Chloride | 12 | $424 | $35 |
| Hydralazine | 21 | $376 | $18 |
| Pantoprazole | 14 | $324 | $23 |
| Warfarin | 37 | $307 | $8 |
| Gabapentin | 18 | $162 | $9 |
| Spironolactone | 16 | $139 | $9 |
| Carvedilol | 22 | $107 | $5 |
| Amlodipine Besylate | 19 | $85 | $4 |
2018: 14 drugs
| Valganciclovir | 14 | $21,543 | $1,539 |
| Tacrolimus | 19 | $1,393 | $73 |
| Gabapentin | 21 | $998 | $48 |
| Warfarin | 33 | $398 | $12 |
| Hydralazine | 27 | $269 | $10 |
| Isosorbide Mononitrate Er | 13 | $217 | $17 |
| Spironolactone | 18 | $170 | $9 |
| Doxycycline Hyclate | 11 | $161 | $15 |
| Lisinopril | 18 | $150 | $8 |
| Pantoprazole | 13 | $109 | $8 |
| Carvedilol | 13 | $90 | $7 |
| Furosemide | 16 | $70 | $4 |
| Sulfamethoxazole-Trimethoprim | 13 | $60 | $5 |
| Clonidine | 12 | $50 | $4 |
2017: 13 drugs
| Digoxin | 22 | $620 | $28 |
| Doxycycline Hyclate | 11 | $518 | $47 |
| Lisinopril | 52 | $323 | $6 |
| Warfarin | 21 | $265 | $13 |
| Hydralazine | 11 | $244 | $22 |
| Gabapentin | 20 | $240 | $12 |
| Isosorbide Mononitrate Er | 13 | $160 | $12 |
| Carvedilol | 29 | $137 | $5 |
| Amlodipine Besylate | 30 | $118 | $4 |
| Clopidogrel | 21 | $118 | $6 |
| Losartan | 18 | $84 | $5 |
| Pantoprazole | 14 | $74 | $5 |
| Furosemide | 17 | $37 | $2 |
2016: 5 drugs
| Lisinopril | 26 | $390 | $15 |
| Potassium Chloride | 13 | $267 | $21 |
| Amlodipine Besylate | 26 | $229 | $9 |
| Spironolactone | 16 | $194 | $12 |
| Carvedilol | 19 | $158 | $8 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 32 | $1,109 | $35 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 14 | $157 | $11 |
Money from drug and device companies
$43 in 2025
| 2025 | 1 | 1 | None | $43 |
| 2024 | 1 | 1 | None | $209 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CVRx | Barostim Neo System | $43 | 1 payment
|
See the published payment
| CVRx | Meals · 2025-07-14 | Barostim Neo System | $43 |
See earlier years (2024)
2024: $209
| Paragonix Technologies | Sherpapak | $209 | 1 payment
|
Professional record
- NPI
- 1720330921
- Licence
- CA 23230California A23230: Cancelled
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, surgical (363AS0400X)
- Mailing address
- 1804 Embarcadero Rd, Suite 100, Palo Alto, CA, 94303
- NPI first listed
- 2012-10-11
- NPI last updated
- 2023-07-06
- NPI record certified
- 2023-07-06
This is when the NPI record was last certified, not a medical board exam.